B. Li, “Effects of Canagliflozin on Fatty Liver Indexes in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials”, J Pharm Pharm Sci, vol. 21, no. 1, pp. 222–235, Jun. 2018.